Xtant Medical Holdings (XTNT) Change in Accured Expenses (2010 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Change in Accured Expenses came in at $958000.0 in Q3 2025, up 333.48% year-over-year from $221000.0 in Q3 2024, and up 4065.22% quarter-over-quarter from $23000.0 in Q2 2025.
Analysis
Xtant Medical Holdings (XTNT) Change in Accured Expenses (2010 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Change in Accured Expenses for 16 consecutive years, with $958000.0 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Change in Accured Expenses rose 333.48% year-over-year to $958000.0 in Q3 2025; TTM through Sep 2025 was $2.6 million, a 724.76% increase from a year earlier, with the FY2024 full-year figure at -$2.9 million, down 176.95% from the prior year.
- Change in Accured Expenses was $958000.0 for Q3 2025 at Xtant Medical Holdings, up from $23000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $2.7 million in Q1 2025 and troughed at -$1.6 million in Q3 2021.
- A 5-year average of $243526.3 and a median of $221000.0 in 2024 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses jumped 10636.36% in 2021 and tumbled 788.78% in 2024, its largest moves.
- Over 5 years, Change in Accured Expenses stood at $270000.0 in 2021, then soared by 75.93% to $475000.0 in 2022, then jumped by 198.74% to $1.4 million in 2023, then plunged by 175.55% to -$1.1 million in 2024, then soared by 189.37% to $958000.0 in 2025.
- The last three Change in Accured Expenses figures came in at $958000.0 (Q3 2025), $23000.0 (Q2 2025), and $2.7 million (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -74.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Xtant Medical Holdings | 47.61 Mn | 30.01 Mn | 17.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 958,000.00 |
| Jun 30, 2025 | 23,000.00 |
| Mar 31, 2025 | 2.74 Mn |
| Dec 31, 2024 | -1.07 Mn |
| Sep 30, 2024 | 221,000.00 |
| Jun 30, 2024 | -1.39 Mn |
| Mar 31, 2024 | -675,000.00 |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 660,000.00 |
| Mar 31, 2023 | 98,000.00 |
| Dec 31, 2022 | 475,000.00 |
| Sep 30, 2022 | 482,000.00 |
| Jun 30, 2022 | 194,000.00 |
| Mar 31, 2022 | -5,000.00 |
| Dec 31, 2021 | 270,000.00 |
| Sep 30, 2021 | -1.65 Mn |
| Jun 30, 2021 | 1.16 Mn |
| Mar 31, 2021 | -893,000.00 |
| Dec 31, 2020 | 77,000.00 |